Search
for
Sort by
Research 631–660 of 1000+
- Evaluation of the safety and effectiveness of intradermal administration of QR678 Neo<sup>®</sup> hair growth factor formulation: A phase‐IV, open‐label, single‐arm multi‐ethnicity clinical trial
- Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical study
- Correction to “Efficacy of Autologous Dermal Sheath Cup Cell Transplantation in Male and Female Pattern Hair Loss: A Single‐Arm, Multi‐Center, Phase III Equivalent Clinical Study”
- Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical study
- Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical study
- Efficacy of autologous dermal sheath cup cell transplantation in male and female pattern hair loss: A Single‐Arm, Multi‐Center, phase III equivalent clinical study
- Effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial
- Effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial
- Effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial
- Effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial
- ISID1077 – Efficacy and safety of ENERGI-F701 solution versus 2% minoxidil solution for female pattern hair loss: a phase II, multi-center, randomized, double-blind, head-to-head, parallel trial
- 1077 Efficacy and safety of ENERGI-F701 solution versus 2% minoxidil solution for female pattern hair loss: a phase II, multi-center, randomized, double-blind, head-to-head, parallel trial
- 602 Efficacy of autologous cell-based therapy for male and female pattern hair loss using dermal sheath cup cells: A single arm, multi-center, confirmatory clinical study
- Skin and hair on-a-chip: in vitro skin models versus ex vivo tissue maintenance with dynamic perfusion
- Epidermal stem cell diversity and quiescence
- Wounding induces dedifferentiation of epidermal Gata6+ cells and acquisition of stem cell properties
- Human skin stem cells and the ageing process
- The in vitro properties of dermal papilla cell lines established from human hair follicles
- Characteristic features of Japanese women's hair with aging and with progressing hair loss
- Serial sections of atrophic acne scars help in the interpretation of microscopic findings and the selection of good therapeutic modalities
- A Successfully Treated Case of Criminal Thallium Poisoning
- Revisiting hyper- and hypo-androgenism by tandem mass spectrometry
- Trichoscopic findings in alopecia areata and their relation to disease activity, severity and clinical subtype in Turkish patients
- Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
- Participation of CD34-enriched mouse adipose cells in hair morphogenesis
- Recipient Area Hair Direction and Angle in Hair Transplanting
- [Implication of VEGF, steroid hormones and neuropeptides in hair follicle cell responses].
- CD49fhigh Defines a Distinct Skin Mesenchymal Stem Cell Population Capable of Hair Follicle Epithelial Cell Maintenance
- The multipotency of adult vibrissa follicle stem cells
- Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19